Literature DB >> 1886444

Quantifying the spread of botulinum toxin through muscle fascia.

C M Shaari1, E George, B L Wu, H F Biller, I Sanders.   

Abstract

Botulinum toxin was recently approved for treating several head and neck dystonias. Paralysis of neighboring muscles is the major complication of its use. Spread of toxin from the injected muscle has been suggested as an etiology. This study examines how botulinum toxin crosses muscle fascia by a novel method of quantifying muscular paralysis. Botulinum toxin (0.2 to 10 U) was placed onto the fascia of rat tibialis anterior (TA) muscles (n = 6). Toxin was also placed on dose-matched muscles that had their fascia surgically removed (n = 6). Twenty-four hours later, the nerve to the tibialis anterior was electrically stimulated to deplete the muscle fibers of glycogen. Toxin-paralyzed fibers retained their glycogen and appeared purple on periodic acid-Schiff (PAS) stain. Botulinum toxin easily passed through muscle fascia even at subclinical doses. The presence of fascia reduced the spread of botulinum toxin by 23%. These results suggest that spread of botulinum toxin can be prevented only by delivering small doses to the center of a target muscle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1886444     DOI: 10.1288/00005537-199109000-00006

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  25 in total

Review 1.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

Review 2.  Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques.

Authors:  A S Schroeder; S Berweck; S H Lee; F Heinen
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

3.  Acute and long-term effects of botulinum neurotoxin on the function and structure of developing extraocular muscles.

Authors:  Scott A Croes; Larisa M Baryshnikova; Soniya S Kaluskar; Christopher S von Bartheld
Journal:  Neurobiol Dis       Date:  2007-01-10       Impact factor: 5.996

4.  Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.

Authors:  Andrea L Nicol; Irene I Wu; F Michael Ferrante
Journal:  Anesth Analg       Date:  2014-06       Impact factor: 5.108

5.  No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm.

Authors:  C Lorenzano; S Bagnato; F Gilio; G Fabbrini; A Berardelli
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 6.  Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.

Authors:  Geoffrey Sheean
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 7.  Botulinum toxin in children with cerebral palsy.

Authors:  Pratibha Singhi; Munni Ray
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

Review 8.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

9.  Determination of injection site in flexor digitorum longus for effective and safe botulinum toxin injection.

Authors:  Hong Geum Kim; Myung Eun Chung; Dae Heon Song; Ju Yong Kim; Bo Mi Sul; Chang Hoon Oh; Nam Su Park
Journal:  Ann Rehabil Med       Date:  2015-02-28

10.  Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them.

Authors:  Mark Hallett
Journal:  Toxicon       Date:  2015-07-26       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.